284 related articles for article (PubMed ID: 22839682)
41. A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis.
Villacorta R; Teeple A; Lee S; Fakharzadeh S; Lucas J; McElligott S
Br J Dermatol; 2020 Sep; 183(3):548-558. PubMed ID: 31840228
[TBL] [Abstract][Full Text] [Related]
42. Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.
Katz P; Nelson WW; Daly RP; Topf L; Connolly-Strong E; Reed ML
J Manag Care Spec Pharm; 2020 Mar; 26(3):275-283. PubMed ID: 32105178
[TBL] [Abstract][Full Text] [Related]
43. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis.
Silverman S; Dukes EM; Johnston SS; Brandenburg NA; Sadosky A; Huse DM
Curr Med Res Opin; 2009 Apr; 25(4):829-40. PubMed ID: 19220165
[TBL] [Abstract][Full Text] [Related]
44. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
45. Direct and indirect costs attributable to osteoarthritis in active subjects.
Rabenda V; Manette C; Lemmens R; Mariani AM; Struvay N; Reginster JY
J Rheumatol; 2006 Jun; 33(6):1152-8. PubMed ID: 16755664
[TBL] [Abstract][Full Text] [Related]
46. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
47. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.
Birnbaum HG; Kessler RC; Kelley D; Ben-Hamadi R; Joish VN; Greenberg PE
Depress Anxiety; 2010; 27(1):78-89. PubMed ID: 19569060
[TBL] [Abstract][Full Text] [Related]
48. The Burden of Illness of Migraine in Canada: New Insights on Humanistic and Economic Cost.
Amoozegar F; Khan Z; Oviedo-Ovando M; Sauriol S; Rochdi D
Can J Neurol Sci; 2022 Mar; 49(2):249-262. PubMed ID: 33875042
[TBL] [Abstract][Full Text] [Related]
49. Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States.
Soliman AM; Surrey E; Bonafede M; Nelson JK; Castelli-Haley J
Adv Ther; 2018 Mar; 35(3):408-423. PubMed ID: 29450864
[TBL] [Abstract][Full Text] [Related]
50. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
[TBL] [Abstract][Full Text] [Related]
51. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
Buono JL; Mathur K; Averitt AJ; Andrae DA
J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
[TBL] [Abstract][Full Text] [Related]
52. Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden.
Skaer TL
Pharmacoeconomics; 2014 May; 32(5):457-66. PubMed ID: 24504852
[TBL] [Abstract][Full Text] [Related]
53. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study.
Gibson PR; Vaizey C; Black CM; Nicholls R; Weston AR; Bampton P; Sparrow M; Lawrance IC; Selby WS; Andrews JM; Walsh AJ; Hetzel DJ; Macrae FA; Moore GT; Weltman MD; Leong RW; Fan T
J Crohns Colitis; 2014 Jul; 8(7):598-606. PubMed ID: 24345767
[TBL] [Abstract][Full Text] [Related]
54. Impact of the severity of hypoglycemia on health - Related quality of life, productivity, resource use, and costs among US patients with type 2 diabetes.
Pawaskar M; Iglay K; Witt EA; Engel SS; Rajpathak S
J Diabetes Complications; 2018 May; 32(5):451-457. PubMed ID: 29496365
[TBL] [Abstract][Full Text] [Related]
55. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
[TBL] [Abstract][Full Text] [Related]
56. Healthcare resource use and indirect costs associated with migraine in Italy: results from the
Martelletti P; Schwedt TJ; Vo P; Ritrovato D; Reilly MC; Naclerio M; Ranjan P; Kleebach J; Joshi P
J Med Econ; 2021; 24(1):717-726. PubMed ID: 33955821
[TBL] [Abstract][Full Text] [Related]
57. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
Holko P; Kawalec P; Mossakowska M; Pilc A
PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
[TBL] [Abstract][Full Text] [Related]
58. Are pain severity and current pharmacotherapies associated with quality of life, work productivity, and healthcare utilisation for people with osteoarthritis in five large European countries?
Conaghan PG; Doane MJ; Jaffe DH; Dragon E; Abraham L; Viktrup L; Bushmakin AG; Cappelleri JC; Perrot S
Clin Exp Rheumatol; 2021; 39(4):819-828. PubMed ID: 32896256
[TBL] [Abstract][Full Text] [Related]
59. The costs associated with sleep symptoms among patients with fibromyalgia.
Wagner JS; Chandran A; DiBonaventura M; Cappelleri JC
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):131-9. PubMed ID: 23402453
[TBL] [Abstract][Full Text] [Related]
60. Burden of HIV-Related Neuropathic Pain in the United States.
Mann R; Sadosky A; Schaefer C; Baik R; Parsons B; Nieshoff E; Stacey BR; Tuchman M; Nalamachu S
J Int Assoc Provid AIDS Care; 2016; 15(2):114-25. PubMed ID: 26173942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
